Literature DB >> 15517500

Antibiotic misuse in medium-sized Swiss hospitals.

Av Bugnon-Reber1, A de Torrenté, N Troillet, D Genné.   

Abstract

Antibiotics account for a substantial proportion of hospital drug expenditures and tend to be misused or overused, generating unnecessary costs and causing the emergence of resistant bacteria. Antibiotic use was evaluated in a one-day prevalence study performed on the surgical and medical wards of eight Swiss non-university hospitals. 173 of the 695 inpatients present (25%) were on antibiotics and 163 could be evaluated. 35 prescriptions were secondary to an infectious disease consultation. 60 of the remaining 128 (47%) were considered inappropriate, of which 17 (28%) lacked any indication for antibiotic use. The rates of misuse were higher in surgery than in medicine (58 vs. 34%; OR = 2.5 [95% CI: 1.1-5.9]), and higher for prophylaxis than for treatment (72 vs. 41%; OR = 4.1 [95% CI: 1.3-15.5]). Savings of 545 euros (95% CI: from -116 to 1,206 euros) on the study day and 6,256 euros (95% CI: from -2,221 to 14,732 euros) for the total treatments or prophylaxis administered would have resulted from infectious disease consultations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517500     DOI: 2004/33/smw-10599

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  13 in total

Review 1.  Drug utilization review across jurisdictions--a reality or still a distant dream?

Authors:  Lisa K Pulver; Susan E Tett
Journal:  Eur J Clin Pharmacol       Date:  2006-01-10       Impact factor: 2.953

2.  Antibiotic misuse: a prospective clinical audit in a French university hospital.

Authors:  C Pulcini; E Cua; F Lieutier; L Landraud; P Dellamonica; P M Roger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-04       Impact factor: 3.267

3.  Hungarian hospital antibiotic consumption at the regional level, 1996-2005.

Authors:  R Benko; M Matuz; P Doro; R Viola; E Hajdu; D L Monnet; G Soos
Journal:  Infection       Date:  2009-01-23       Impact factor: 3.553

4.  Different patterns of inappropriate antimicrobial use in surgical and medical units at a tertiary care hospital in Switzerland: a prevalence survey.

Authors:  Alexia Cusini; Silvana K Rampini; Vineeta Bansal; Bruno Ledergerber; Stefan P Kuster; Christian Ruef; Rainer Weber
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

5.  Economic burden of inappropriate antibiotic use for prophylactic purpose in shiraz, iran.

Authors:  N Hatam; M Askarian; A R Moravveji; O Assadian
Journal:  Iran Red Crescent Med J       Date:  2011-04-01       Impact factor: 0.611

6.  Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study.

Authors:  Julian Mettler; Mathew Simcock; Pedram Sendi; Andreas F Widmer; Roland Bingisser; Manuel Battegay; Ursula Fluckiger; Stefano Bassetti
Journal:  BMC Infect Dis       Date:  2007-03-26       Impact factor: 3.090

7.  Appropriateness of gram-negative agent use at a tertiary care hospital in the setting of significant antimicrobial resistance.

Authors:  Neil M Vora; Christine J Kubin; E Yoko Furuya
Journal:  Open Forum Infect Dis       Date:  2015-02-19       Impact factor: 3.835

8.  Economic Burden Of Inappropriate Empiric Antibiotic Therapy: A Report From Southern Iran.

Authors:  Arman Sadatsharifi; Mohammad-Ali Davarpanah; Soha Namazi; Shaghayegh Mottaghi; Laleh Mahmoudi
Journal:  Risk Manag Healthc Policy       Date:  2019-12-12

9.  Outcomes of early switching from intravenous to oral antibiotics on medical wards.

Authors:  Dominik Mertz; Michael Koller; Patricia Haller; Markus L Lampert; Herbert Plagge; Balthasar Hug; Gian Koch; Manuel Battegay; Ursula Flückiger; Stefano Bassetti
Journal:  J Antimicrob Chemother       Date:  2009-04-28       Impact factor: 5.790

10.  Assisted knowledge discovery for the maintenance of clinical guidelines.

Authors:  Emilie Pasche; Patrick Ruch; Douglas Teodoro; Angela Huttner; Stephan Harbarth; Julien Gobeill; Rolf Wipfli; Christian Lovis
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.